SCHEMBL7471507

SCHEMBL7471507

C[C@@H](O)C(Cc1ccc(Cl)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK5 Q9Y337 2/20 0.49
PPARG P37231 1/20 0.49
PPARA Q07869 1/20 0.49
GAA P10253 1/20 0.48
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
TRPA1 O75762 1/20 0.45
CACNA1B Q00975 1/20 0.45
LMNA P02545 1/20 0.45
TSHR P16473 1/20 0.45
ATM Q13315 1/20 0.44
CNR1 P21554 3/20 0.44
CNR2 P34972 2/20 0.44
CTSS P25774 2/20 0.44
CTSK P43235 2/20 0.44
PSEN1 P49768 2/20 0.43
PSEN2 P49810 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7471521 1.00 KLK5 (0.49) KLK5PPARGPPARAGAAALDH1A1
SCHEMBL7471500 1.00 KLK5 (0.49) KLK5PPARGPPARAGAAALDH1A1
SCHEMBL13932828 0.90 CA1 (0.54) KLK5PPARGPPARAGAAALDH1A1
SCHEMBL6730484 0.88 PPARA (0.54) KLK5PPARGPPARAGAACACNA1B
SCHEMBL31177405 0.88 PPARA (0.54) KLK5PPARGPPARAGAACACNA1B
SCHEMBL8486327 0.86 KLK5 (0.63) KLK5ATMCTSSCTSKPSEN1
SCHEMBL27486450 0.86 KLK5 (0.63) KLK5ATMCTSSCTSKPSEN1
SCHEMBL27796636 0.86 KLK5 (0.63) KLK5ATMCTSSCTSKPSEN1
SCHEMBL27502332 0.86 KLK5 (0.63) KLK5ATMCTSSCTSKPSEN1
SCHEMBL31177569 0.86 KLK5 (0.54) KLK5PPARGPPARAGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923550-B1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS NOVARTIS AG (CH) 2002-09-25 EP disclosed
US-6319917-B1 NEUROGENIC INFLAMMATION AND TACHYKININ BRONCHOCONSTRICTION INHIBITORS NOVARTIS AG (CH) 2001-11-20 US disclosed
EP-0923550-A1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS Novartis AG (CH) 1999-06-23 EP disclosed
WO-1998007694-A1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS NOVARTIS AG (CH) 1998-02-26 WO disclosed